21.02.2018 | Reply
Authors’ reply to Gandjour: “Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany”
Erschienen in: The European Journal of Health Economics | Ausgabe 3/2018
Einloggen, um Zugang zu erhaltenExcerpt
We thank Professor Gandjour for the interest in our article. His comments [1] show that some findings of our study [2] may require a more detailed explanation considering the complexity of the topic: modeling the effects and cost-effectiveness of vaccines including indirect effects. We are grateful for the opportunity to clarify the issues raised by Gandjour. In the following, we will give a point-by-point reply and present results of additional analyses. …Anzeige